> Technologies 2012
BioVaria's technologies are presented as an all-day poster exhibition that enables industry representatives to gain a unique overview of undiscovered, licensable technologies and to discuss scientific details face-to-face with the inventors.
Additionally half of the technologies (marked with an *) will also be presented as 10-min talks.
| Cardiovascular | |
| > A1* | MicroRNAs as therapeutic targets for treatment or prevention of cardiac disorders Prof. Thomas Thum, Dr Kamal Chowdhury, Dr Ahmed Ucar, Claudia Bang, Shashi Kumar Gupta |
| > A6 | Novel eicosanoid-like antiarrhythmic drugs Dr Wolf-Hagen Schunck, Dr Robert Fischer, Prof. Dominik N. Müller, Prof. John R. Falck |
| > T2* |
Dr Bengt Erik Haug, Prof. Leiv K. Sydnes |
| > U4 | Transcription factors for the modulation of collagen synthesis in fibrotic disease Dr Michael Czubryt |
| > U5 | Treatment of mycocardial collapse in acute sepsis Dr Steven Mink |
| > W4 | New target for the treatment of oxidative stress Prof. Christoph J. Binder, Dr David Weismann |
| Diagnostics | |
| > B3 | LASP-1, a diagnostic marker for bladder cancer Prof. Elke Butt, Dr Peter Ardelt |
| > E2* | Biomarkers for Parkinson's disease dementia Prof. Markus Otto |
| > F3* | New compounds to discriminate normal from prion-infected samples: application for diagnosis Dr Véronique Perrier, Thibaut Imberdis, Dr Jean-Michel Verdier, Dr Mike Robitzer |
| > I1* | Chemerin9 variants for diagnosis and therapy of pancreatic and oesophageal cancer Prof. Bertram Wiedenmann, Dr Carsten Grötzinger, Sebastian Bandholtz |
| > I3 | A method for restoring BMP-receptor signaling in a cell Prof. Petra Knaus, Dr Raphaela Schwappacher |
| > L3* | The M3 kit: a multimarker methylation kit for the diagnosis and prognosis of prostate cancer Prof. Mathieu Bollen, Prof. Aleyde Van Eynde |
| > P2* | 2-Gene biomarker panel for early detection of bladder cancer from urine Prof. Edgar Dahl, Michael Rose |
| > P3 | Parkinson risk assessment out of blood samples Prof. Ullrich Wüllner, Dr Ina Schmitt |
| > P4 |
Prof. Joachim L. Schultze, Andrea Hofmann, Dr Andrea Startschek-Jox |
| > T3 | Novel PET probes for molecular imaging of single kidney function Prof. Olav Tenstad |
| > W2* | New biomarkers for therapeutic response to PI3K pathway inhibitors in cancer Dr Sebastian Nijman, Dr Markus Muellner |
| > W3 | Cancer relapse detection and cancer treatment monitoring Martina Schwarz, Dr Marcus Otte |
| > W5 | New biomarker for diseases of oxidative stress Prof. Christoph Binder, Dr David Weismann |
| Drug Delivery | |
| > I4 | Bisphosphonates as potential drug candidates for inflammatory lung diseases Prof. Christoph Arenz, Prof. Stephan Uhlig, Anke Gundula Roth, Daniela Drescher |
| > I5 | New pill package - applicator for ointments Claudia Hauser |
| Drug Development | |
| > E1* | Cell-permeable peptide modulators of protein phosphatase 1 Dr Maja Koehn, Dr Matthieu Bollen |
| > L1* | Novel structural analogues of vitamin D Prof. Roger Bouillon, Prof. Pierre De Clercq, Prof. Mieke Verstuyf |
| > U3 | Novel Aminoglycoside chemistries to treat antibiotic–resistant, hospital acquired infections Dr George Zhanel, Dr Frank Schweizer |
| Immune/Autoimmune | |
| > A3 | Innovative tags to increase specificity of complement system inhibitors for therapeutic use Prof. Peter Zipfel, Nadine Lauer, Dr Stefan Heinen, Dr Hans-Martin Dahse, Prof. John Lambris |
| > A4 | CFHR proteins – Novel regulators of the innate immune system Prof. Peter Zipfel, Dr Christine Skerka, Dr Reinhard Wallich |
| > B4 |
Prof. Christoph Becker, Claudia Günther |
| > E5 | Use of IGF-1 for the treatment of autoimmune diseases Prof. Nadia Rosenthal |
| > L2* | Novel MALT1 protease inhibitors for the treatment of immune-mediated and neoplastic diseases Dr Thijs Baens, Prof. Rudy Beyaert |
| > T1* | Treatment of Chronic Fatigue Syndrome / Myalgic Encephalomyelitis (CFS/ME) Prof. Olav Mella, Dr Øystein Fluge |
| > U1* | Semaphorin 3E protein as a biomarker and a potential biologic treatment for asthma Dr Soussi Gounni |
| > U2* | FDC-SP and related peptides for treatment of IgAN Dr Aaron Marshall |
| Infection | |
| > F5 | A new strategy based on NADPH depletion to combat malarial parasites Dr Elisabeth Davioud-Charvet, Dr Antoine Lanfranchi, Prof. Heiner Schirmer |
| > I2 | Viral vector system for the controllable expression of transgenes Dr Henry Fechner |
| > P6 | Compounds regulating the thi-box riboswitch Prof. Günter Mayer, Christina E. Lünse, Prof. Colin Suckling, Fraser Scott |
| > W1* | Resistance-breaking inhibitors for the prevention and treatment of influenza infections Prof. Klaus Liedl, Dr Michaela Schmidtke, Dr Johannes Kirchmair, Prof. Judith M. Rollinger |
| Neurological Disorders | |
| > B2* | Identification of a novel class of multifunctional drugs for treatment of Alzheimer´s disease Prof. Jochen Herms, Kamran Honarnejad, Alexander Daschner, Prof. Franz Bracher, André Philipe Gehring |
| > F6 | New insights in treating anorexia and bulimia: Innovative targets Prof. Valérie Compan |
| > L5 | TRPM8 antagonists for the treatment of cold allodynia and neuropathic pain Prof. Thomas Voets |
| > P1* | Treating Alzheimer´s disease by targeting Amyloid ß-nitration Prof. Michael Heneka, Dr Markus Kummer |
| Oncology | |
| > A5 | Novel antibody to carbonic anhydrase XII (CA XII) with therapeutic and diagnostic potential Prof. Reinhard Zeidler, Dr Christina Battke, Dr Elisabeth Kremmer, Andrew Flatley, Prof. Claudiu Supuran |
| > E4 | Small Molecule Inhibitors of Tec Kinase/FGF2 interaction to prevent FGF2 mediated angiogenesis Prof. Walter Nickel |
| > F1* | A LIM Kinase inhibitor for the treatment of primary and metastatic cancers Dr Laurence Lafanechère, Dr Renaud Prudent, Dr Caroline Barette, Dr Chi-Hung Nguyen, Dr Christian Rivalle |
| > F2* |
Dr Robert Dodd, Dr Joanna Bakala |
| > L4 | Novel and potent lactate flux inhibitors Prof. Olivier Feron |
| > M1* | Novel inhibitors for Rab Geranylgeranyl Transferase (Rabi) Dr Axel Choidas, Dr Raffaela Di Lucrezia, Prof. Herbert Waldmann, Prof. Roger Goody |
| Pneumology | |
| > A2* | Glycogen synthase kinase 3 (GSK-3) inhibitors for use in treating lung emphysema Dr Melanie Königshoff, Prof. Oliver Eickelberg |
| Regenerative Medicine | |
| > C1* |
Dr Nerea Garagorri, Dr Beatriz Olalde, Iratxe Madarieta |
| Tools | |
| > B1* |
Prof. Thomas Lahaye, Prof. Heinrich Leonhardt, Robert Morbitzer, Sebastian Bultmann |
| > E3 | Microfluidic chip to identify inhibitors of cancer metastasis Prof. Stefan Schneider |
| > F4 | High-throughput single-DNA chip Dr Laurence Salomé, Dr Thomas Plénat, Dr Catherine Tardin, Dr Christophe Thibault, Dr Emmanuelle Trévisiol |
| > P5 | Determination of cellular aging in cell cultures Prof. Wolfgang Wagner, Sylvia Joussen, Dr Carmen Koch, Anne Schellenberg |